Document is current
Any future updates will be listed below
-
Authors
Wu, Yidong https://orcid.org/0000-0003-0232-5100
Zhao, Tianyuan
Wang, Yazhi
Zhang, Ting
Hang, Chenyue
Wang, Yafang
Liu, Yang
Chen, Zhixuan
Chen, Jieqiong
Li, Tong https://orcid.org/0000-0002-2544-1254
Sun, Junran
Jia, Huixun https://orcid.org/0000-0001-9341-5587
Zhang, Lei
Wang, Fenghua
Wan, Xiaoling https://orcid.org/0000-0003-4583-8686
Sun, Xiaodong https://orcid.org/0000-0001-5015-0945
-
Funding
Funding for this research was provided by:
Shanghai Science and Technology Development Foundation (24YF2734000)
- License Information
-
More Information
Article History
Received: 12 July 2024
Accepted: 21 August 2025
First Online: 2 September 2025
Competing interests
: F.W. is an equity owner of Innostellar Biotherapeutics, a company developing human gene therapies. The remaining authors declare no competing interests.
